SCM
JBIO

Soleus Capital Management’s Jade Biosciences JBIO Stock Holding History

Soleus Capital Management’s Portfolio JBIO Stock Details JBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$34.5M Buy
1,550,690
+753,946
+95% +$15.7M 1.19% 26
2026
Q1 		$11.2M Hold
796,744
– – 0.45% 46
2025
Q4 		$12.3M Hold
796,744
– – 0.45% 47
2025
Q3 		$6.88M Hold
796,744
– – 0.35% 54
2025
Q2 		$7.96M Buy
+796,744
New +$27.1M 0.53% 45
2023
Q1 		– Sell
-6,203
Closed -$6.36M – 79
2022
Q4 		$6.36M Buy
+6,203
New +$4.5M 0.91% 33

Other funds holding JBIO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Soleus Capital Management's JBIO Position: Q2 2026 in Review

Soleus Capital Management increased its Jade Biosciences (JBIO) stake by 95% in Q2 2026, buying an estimated $15.7M and bringing the position to 1,550,690 shares worth $34.5M. The position accounts for 1.19% of the portfolio, ranked #26.

Soleus Capital Management first reported a position in JBIO in Q4 2022 and has held it in 6 quarters since. 154 funds tracked by Wall St. Rank hold JBIO as of Q2 2026.

  • Soleus Capital Management held 1,550,690 shares of Jade Biosciences worth $34.5M as of Q2 2026.
  • Soleus Capital Management bought 753,946 Jade Biosciences shares in Q2 2026, an estimated $15.7M.
  • Jade Biosciences made up 1.19% of Soleus Capital Management's portfolio in Q2 2026, its #26 holding.
  • Soleus Capital Management first reported a position in Jade Biosciences in Q4 2022 and has held it in 6 quarters since.
  • 154 funds tracked by Wall St. Rank held Jade Biosciences as of Q2 2026.

Based on Soleus Capital Management's 13F filing for Q2 2026, filed 11 Aug 2026.